食品添加剂防腐剂摄入与癌症发病率:NutriNet-Santé前瞻性队列研究结果
OBJECTIVE: To investigate the association between intake of food additive preservatives and cancer incidence in a large prospective cohort. DESIGN: Prospective cohort. SETTING: French NutriNet-Santé cohort, 2009-23.…
要点
- 总非抗氧化剂高摄入者相比非消费者或低消费者,总体癌症风险升高(HR 1.16,95%CI 1.07-1.26),60岁时绝对风险分别为13.3%和12.1%。
- 山梨酸钾高摄入与总体癌症(HR 1.14,95%CI 1.04-1.24)和乳腺癌(HR 1.26,95%CI 1.07-1.49)风险升高相关。
- 亚硝酸钠高摄入与前列腺癌风险升高相关(HR 1.32,95%CI 1.02-1.70),绝对风险分别为4.2%和3.4%。
核心结论
- 在大型前瞻性队列中观察到工业食品中广泛使用的多种防腐剂摄入与总体癌症、乳腺癌和前列腺癌发病率之间存在多重正相关。
- 需要基于健康效应生物标志物的流行病学研究和实验研究来深入了解结局通路。
- 若这些新数据得到确认,则呼吁重新评估食品工业使用这些添加剂的法规以改善消费者保护。
- 与此同时,研究结果支持推荐消费者优先选择新鲜制作、最低限度加工的食物。
研究设计与样本
- 通过重复24小时膳食记录评估防腐剂累积时间依赖性摄入量,包括工业食品品牌中的防腐剂,并利用多个成分数据库和针对最常消费的添加剂-食品配对的食品产品实验室检测进行评估。
- 采用多变量比例风险Cox模型分析三类防腐剂摄入与癌症发病率之间的关联,模型调整了潜在混杂因素。
- 防腐剂摄入分类定义为:若至少三分之一的参与者消费该防腐剂,则按性别特异性三分位数分组;否则分为非消费者和以性别特异性中位数分隔的较低或较高消费者。
主要发现
- 参与者平均年龄42.0岁(标准差14.5岁),78.7%为女性;4226名参与者被诊断为 incident癌症(平均随访7.57年,标准差4.56年),包括1208例乳腺癌、508例前列腺癌、352例结直肠癌和2158例其他癌症。
- 总非抗氧化剂高摄入者相比非消费者或低消费者,总体癌症风险升高(HR 1.16,95%CI 1.07-1.26),60岁时癌症绝对风险分别为13.3%和12.1%;乳腺癌风险升高(HR 1.22,95%CI 1.05-1.41),绝对风险分别为5.7%和4.8%。
- 总山梨酸盐(特别是山梨酸钾)高摄入者相比非消费者或低消费者,总体癌症风险升高(HR 1.14,95%CI 1.04-1.24),绝对风险分别为13.4%和11.8%;乳腺癌风险升高(HR 1.26,95%CI 1.07-1.49),绝对风险分别为5.7%和4.6%。
- 总亚硫酸盐高摄入者相比非消费者或低消费者,总体癌症风险升高(HR 1.12,95%CI 1.02-1.24),绝对风险分别为13.4%和11.9%;焦亚硫酸钾高摄入者总体癌症风险升高(HR 1.11,95%CI 1.03-1.20),绝对风险分别为13.5%和12.0%,乳腺癌风险升高(HR 1.20,95%CI 1.04-1.38),绝对风险分别为5.7%和4.9%。
- 亚硝酸钠高摄入者相比非消费者或低消费者,前列腺癌风险升高(HR 1.32,95%CI 1.02-1.70),绝对风险分别为4.2%和3.4%;硝酸钾高摄入者总体癌症风险升高(HR 1.13,95%CI 1.05-1.23),绝对风险分别为14.0%和12.0%,乳腺癌风险升高(HR 1.22,95%CI 1.05-1.41),绝对风险分别为5.9%和4.8%。
关键数值与推荐
- 总非抗氧化剂:高摄入 vs 非消费者或低消费者,总体癌症 HR 1.16(95%CI 1.07-1.26),60岁时绝对风险 13.3% vs 12.1%;乳腺癌 HR 1.22(95%CI 1.05-1.41),绝对风险 5.7% vs 4.8%。
- 总山梨酸盐(特别是山梨酸钾):高摄入 vs 非消费者或低消费者,总体癌症 HR 1.14(95%CI 1.04-1.24),绝对风险 13.4% vs 11.8%;乳腺癌 HR 1.26(95%CI 1.07-1.49),绝对风险 5.7% vs 4.6%。
- 总亚硫酸盐:高摄入 vs 非消费者或低消费者,总体癌症 HR 1.12(95%CI 1.02-1.24),绝对风险 13.4% vs 11.9%;焦亚硫酸钾:总体癌症 HR 1.11(95%CI 1.03-1.20),绝对风险 13.5% vs 12.0%;乳腺癌 HR 1.20(95%CI 1.04-1.38),绝对风险 5.7% vs 4.9%。
- 亚硝酸钠:高摄入 vs 非消费者或低消费者,前列腺癌 HR 1.32(95%CI 1.02-1.70),绝对风险 4.2% vs 3.4%;硝酸钾:总体癌症 HR 1.13(95%CI 1.05-1.23),绝对风险 14.0% vs 12.0%;乳腺癌 HR 1.22(95%CI 1.05-1.41),绝对风险 5.9% vs 4.8%。
- 总醋酸盐:高摄入 vs 非消费者或低消费者,总体癌症 HR 1.15(95%CI 1.06-1.25),绝对风险 14.3% vs 12.2%;乳腺癌 HR 1.25(95%CI 1.07-1.45),绝对风险 6.1% vs 4.9%;醋酸:总体癌症 HR 1.12(95%CI 1.01-1.25),绝对风险 14.4% vs 12.4%;异抗坏血酸钠:总体癌症 HR 1.12(95%CI 1.04-1.22),绝对风险 13.5% vs 11.9%;乳腺癌 HR 1.21(95%CI 1.04-1.41),绝对风险 5.7% vs 4.8%。
临床怎么用
- 作者指出,若这些新数据得到确认,则呼吁重新评估食品工业使用这些添加剂的法规,以改善消费者保护。
- 作者指出,与此同时,研究结果支持推荐消费者优先选择新鲜制作、最低限度加工的食物。
- 原文未据此给出其他临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association between intake of food additive preservatives and cancer incidence in a large prospective cohort. DESIGN: Prospective cohort. SETTING: French NutriNet-Santé cohort, 2009-23. PARTICIPANTS: 105 260 participants (≥15 years) without prevalent cancer who completed at least two 24 hour dietary records at baseline. MAIN OUTCOME MEASURES: Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed using repeated 24 hour dietary records and evaluated through multiple composition databases and ad hoc laboratory assays in food products for the most frequently consumed additive-food pairs. Associations between intake of three categories of preservatives (defined as sex specific thirds if preservative was consumed by at least a third of participants, otherwise defined as non-consumers and lower or higher consumers separated by the sex specific median) and cancer incidence were characterised using multivariable proportional hazards Cox models adjusted for potential confounders. RESULTS: Mean age of participants was 42.0 years (standard deviation (SD 14.5) years), and 78.7% were women. 4226 participants received a diagnosis of incident cancer (mean follow-up 7.57 (SD 4.56) years), comprising 1208 breast, 508 prostate, 352 colorectal, and 2158 other cancers). Higher intakes of several preservatives were associated with higher cancer incidence: total non-antioxidants with overall cancer (hazard ratio for higher v non-consumers or lower consumers 1.16 (95% confidence interval (CI) 1.07 to 1.26); absolute risk of cancer at age 60 years, respectively, 13.3%, 12.1%) and breast cancer (1.22 (1.05 to 1.41); 5.7%, 4.8%); total sorbates, specifically potassium sorbate, with overall cancer (1.14 (1.04 to 1.24); 13.4%, 11.8%) and breast cancer (1.26 (1.07 to 1.49); 5.7%, 4.6%); total sulfites with overall cancer (1.12 (1.02 to 1.24); 13.4%, 11.9%); potassium metabisulfite with overall cancer (1.11 (1.03 to 1.20); 13.5%, 12.0%) and breast cancer (1.20 (1.04 to 1.38); 5.7%, 4.9%); sodium nitrite with prostate cancer (1.32 (1.02 to 1.70); 4.2%, 3.4%); potassium nitrate with overall cancer (1.13 (1.05 to 1.23); 14.0%, 12.0%) and breast cancer (1.22 (1.05 to 1.41); 5.9%, 4.8%); total acetates with overall cancer (1.15 (1.06 to 1.25); 14.3%, 12.2%) and breast cancer (1.25 (1.07 to 1.45); 6.1%, 4.9%); acetic acid with overall cancer (1.12 (1.01 to 1.25); 14.4%, 12.4%); and sodium erythorbate with overall cancer (1.12 (1.04 to 1.22); 13.5%, 11.9%) and breast cancer (1.21 (1.04 to 1.41); 5.7%, 4.8%). 11 of the 17 individually studied preservatives were not associated with cancer incidence. CONCLUSION: Multiple positive associations between intake of preservatives widely used in industrial foods and higher cancer incidence (overall, breast, and prostate) were observed in this large prospective cohort. Epidemiology based on health effect biomarkers and experimental research are needed to gain insight into outcome pathways. If confirmed, these new data call for the re-evaluation of regulations governing the food industry's use of these additives, to improve consumer protection. In the meantime, the findings support recommendations for consumers to favour freshly made, minimally processed foods. TRIAL REGISTRATION: ClinicalTrials.gov NCT03335644.
引用
- Hasenböhler A, Javaux G, Payen de la Garanderie M, et al. Intake of food additive preservatives and incidence of cancer: results from the NutriNet-Santé prospective cohort. BMJ. 2026. PMID: 41500678. doi:10.1136/bmj-2025-084917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。